Authors
Thomas V. Johnson III, MD, PhD, is chief of the Glaucoma Division and the Shelley and Allan Holt Rising Professor of Ophthalmology at the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland.
Felfeli is a resident at the University of Toronto in Toronto, Canada.
Uday Devgan, MD, FACS, is with Devgan Eye Surgery in Los Angeles, California.
Berry is a senior research fellow at UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, United Kingdom.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
One day, three approvals: FDA expands options for ocular redness, thyroid eye disease, and presbyopia
2
Duravyu misses wet AMD end point again as EyePoint pivots to DME
3
The Retina TL;DR with Dr. Weng: Thriving in fellowship with Amer Alsoudi, MD, and Monia Reding, MD
4
Brepocitinib meets all Phase 3 end points in noninfectious uveitis
5